NYSE:DHR - Danaher Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$100.71 +0.62 (+0.62 %)
(As of 08/16/2018 10:49 AM ET)
Previous Close$100.54
Today's Range$100.17 - $100.89
52-Week Range$80.44 - $106.08
Volume13,812 shs
Average Volume2.43 million shs
Market Capitalization$70.21 billion
P/E Ratio24.90
Dividend Yield0.64%
Beta1.04
Danaher logoDanaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
SymbolNYSE:DHR
CUSIP23585110
Phone202-828-0850

Debt

Debt-to-Equity Ratio0.41
Current Ratio1.50
Quick Ratio1.07

Price-To-Earnings

Trailing P/E Ratio24.90
Forward P/E Ratio22.43
P/E Growth1.92

Sales & Book Value

Annual Sales$18.33 billion
Price / Sales3.84
Cash Flow$5.8895 per share
Price / Cash17.10
Book Value$37.91 per share
Price / Book2.66

Profitability

EPS (Most Recent Fiscal Year)$4.03
Net Income$2.49 billion
Net Margins13.84%
Return on Equity11.55%
Return on Assets6.53%

Miscellaneous

Employees67,000
Outstanding Shares699,760,000
Market Cap$70.21 billion

Danaher (NYSE:DHR) Frequently Asked Questions

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Tuesday, May 8th. Shareholders of record on Friday, June 29th will be paid a dividend of $0.16 per share on Friday, July 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Thursday, June 28th. View Danaher's Dividend History.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) issued its earnings results on Thursday, July, 19th. The conglomerate reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.06. The conglomerate earned $4.98 billion during the quarter, compared to analyst estimates of $4.91 billion. Danaher had a return on equity of 11.55% and a net margin of 13.84%. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.99 earnings per share. View Danaher's Earnings History.

When is Danaher's next earnings date?

Danaher is scheduled to release their next quarterly earnings announcement on Thursday, October, 18th 2018. View Earnings Estimates for Danaher.

What guidance has Danaher issued on next quarter's earnings?

Danaher updated its FY18 earnings guidance on Thursday, July, 19th. The company provided EPS guidance of $4.43-4.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.44. Danaher also updated its Q3 guidance to $1.05-1.08 EPS.

What price target have analysts set for DHR?

16 equities research analysts have issued 1 year price objectives for Danaher's shares. Their forecasts range from $83.00 to $122.00. On average, they anticipate Danaher's stock price to reach $107.7980 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price. View Analyst Price Targets for Danaher.

What is the consensus analysts' recommendation for Danaher?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 1 hold rating and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.

Who are some of Danaher's key competitors?

Who are Danaher's key executives?

Danaher's management team includes the folowing people:
  • Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 57)
  • Mr. Daniel L. Comas, CFO & Exec. VP (Age 54)
  • Ms. Angela S. Lalor, Sr. VP of HR (Age 53)
  • Mr. William K. Daniel II, Exec. VP (Age 53)
  • Mr. Rainer M. Blair, Exec. VP (Age 54)

Has Danaher been receiving favorable news coverage?

Media headlines about DHR stock have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Danaher earned a news impact score of 0.19 on Accern's scale. They also gave media headlines about the conglomerate an impact score of 46.25 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for Danaher.

Who are Danaher's major shareholders?

Danaher's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.15%), Massachusetts Financial Services Co. MA (3.06%), FMR LLC (3.00%), Putnam Investments LLC (0.91%), Flossbach Von Storch AG (0.79%) and Bank of New York Mellon Corp (0.74%). Company insiders that own Danaher stock include Angela S Lalor, Brian W Ellis, Brijender (Binny) Jass Jassal, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Millennium Management LLC, Brown Advisory Inc., BlackRock Inc., Allen Investment Management LLC, Epoch Investment Partners Inc., Bank of Montreal Can and TD Asset Management Inc.. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.

Which institutional investors are buying Danaher stock?

DHR stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, CIBC World Markets Inc., PNC Financial Services Group Inc., California Public Employees Retirement System, Canada Pension Plan Investment Board, Scopus Asset Management L.P. and Stevens Capital Management LP. Company insiders that have bought Danaher stock in the last two years include Brijender (Binny) Jass Jassal, Donald J Ehrlich and Mitchell P Rales. View Insider Buying and Selling for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $100.35.

How big of a company is Danaher?

Danaher has a market capitalization of $70.21 billion and generates $18.33 billion in revenue each year. The conglomerate earns $2.49 billion in net income (profit) each year or $4.03 on an earnings per share basis. Danaher employs 67,000 workers across the globe.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]


MarketBeat Community Rating for Danaher (NYSE DHR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  797 (Vote Outperform)
Underperform Votes:  435 (Vote Underperform)
Total Votes:  1,232
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.